tiprankstipranks
Trending News
More News >

Christopher John Burns Insider Profile

4 Followers
Christopher John Burns, Managing Director & Chief Executive Officer at Amplia Therapeutics, holds 4.16M shares in Amplia Therapeutics (Ticker: INNMF). Most recently, Christopher John Burns Bought 86,957 shares of Amplia Therapeutics on Sep 08, 2025 for an estimated value of $20.00K.
tipranks
Christopher John  Burns

Christopher John Burns
Amplia Therapeutics (INNMF)
Managing Director & Chief Executive Officer

Ranked #21,975 out of 103,606 Corporate Insiders

Profitable Transactions

40%
2 out of 5 Profitable Transactions

Average Return

+15.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$416K
100.00%
A breakdown of Christopher John Burns's holdings

Insider Roles

Amplia Therapeutics
(INNMF)
Managing Director & Chief Executive Officer
Roles that Christopher John Burns holds in companies

Most Profitable Insider Trade

Stock:
Amplia Therapeutics
(INNMF)
Rating:Informative Buy
Date:Dec 20, 2024 - Today
Return:+91.60%
The most profitable trade made by Christopher John Burns

Christopher John Burns's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Amplia Therapeutics
Sep 08, 2025
Managing Director & Chief Executive Officer
Informative Buy
20.00K
$415.56K
Success Rate for
INNMF
2 out of 5 profitable transactions on
INNMF
40%
Average Return for
INNMF
Average return per transaction on
INNMF
+15.60%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Dec 21, 2021
Informative Buy
AU$10.00K
-
AU$0.18
-50.80%
Aug 05, 2019
Informative Buy
AU$6.00K
-
AU$0.10
+59.60%
Sep 18, 2020
Uninformative Buy
AU$25.00K
-
AU$0.13
May 21, 2024
Informative Buy
AU$33.92K
-
AU$0.06
-15.90%
Aug 26, 2024
Uninformative Buy
AU$36.35K
-
AU$0.06
List of latest transactions for each holding click on a transaction to see Christopher John Burns's performance on stock

Christopher John Burns insider profile FAQ

What is the percentage of profitable transactions made by Christopher John Burns?
The percentage of profitable transactions made by Christopher John Burns is 40%.
    What is the average return per transaction made by Christopher John Burns?
    The average return per transaction made by Christopher John Burns is 15.60%.
      What stocks does Christopher John Burns hold?
      Christopher John Burns holds: INNMF stocks.
        What was Christopher John Burns’s latest transaction?
        Christopher John Burns latest transaction was an Informative Buy of $20.00K.
          What was Christopher John Burns's most profitable transaction?
          Christopher John Burns’s most profitable transaction was an Informative Buy of INNMF stock on December 20, 2024. The return on the trade was 91.60%.
            What is Christopher John Burns's role in Amplia Therapeutics?
            Christopher John Burns's role in Amplia Therapeutics is Managing Director & Chief Executive Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.